Testing laboratory · Reviewed 2026-09-03
Vanguard Laboratory · Olympia, Washington, USA
Legitimacy review
Vanguard is a legitimate operating laboratory with a current A2LA accreditation, named leadership, a Washington entity trail, and transparent peptide services. Its published accredited scope does not expressly cover the headline peptide assays it markets.
The official site lists Dustin Newman as laboratory director and 2635 Parkmont Ln SW, Suite A, Olympia, Washington. The A2LA certificate identifies Olympic Analytical, LLC dba Vanguard Laboratory. A Washington corporate record traces Olympic Analytical LLC to April 15, 2021 and identifies Victoria Johnson in its governance record.
Named director, state entity trail, operating address, current A2LA record, transparent menu and pricing, and public report program.
A2LA certificate 6377.01 is valid through September 30, 2027. Its scope includes enumerated microbiology, trace elements, preservatives, and residual solvents; it does not expressly list peptide HPLC purity, LC-MS identity, quantity, endotoxin, or sterility.
Vanguard publishes individual purity, quantity, identity, endotoxin, metals, microbiology, residual-solvent, and sterility offerings. Its order page lists standard turnaround of five to eight days and a 15-day sterility timeline that includes the 14-day incubation period.
Recent Reddit posts include a same-vial HCG discrepancy reportedly traced to a dilution error and difficulty verifying older reports. These are individual accounts, not a proficiency study.
The accredited scope does not expressly cover the headline peptide assays, and the public verifier is opt-in rather than a complete index of every report Vanguard has issued. An active certificate applies only to the legal entity, site, methods, analytes, and matrices in its published scope.
Vanguard is the trade name of Olympic Analytical LLC, a Washington company formed on April 15, 2021. Its current laboratory address is 2635 Parkmont Ln SW, Suite A, Olympia, and the official site names Dustin Newman as laboratory director. Certificates also identify Tori Johnson in an operations role.
Newman is described by Vanguard as an AFDO-recognized process authority. That is relevant professional context, but it is distinct from the laboratory's A2LA accreditation and from the scope of any peptide-specific method.
A2LA certificate 6377.01 is current through September 30, 2027 and names Olympic Analytical LLC dba Vanguard Laboratory. Its attached scope lists defined food, pharmaceutical, environmental, water, microbiology, trace-element, preservative, and residual-solvent work.
The reviewed scope does not expressly list the peptide HPLC purity, LC-MS identity, net-content, endotoxin, bioburden, or sterility services marketed on Vanguard's peptide page. Washington environmental-laboratory recognition is likewise limited to the listed water work. The defensible description is an accredited operating lab whose confirmed scope does not encompass every advertised peptide assay.
Vanguard publishes unusually transparent ordering information. At the time of review, raw-material purity was listed at $200, purity plus quantity at $250, bacteriostatic-water and pH testing at $200, endotoxin at $210, and several add-on panels at $50 or $150. Bundled panels were listed at $550 and $700. These are dated observations, not permanent price promises.
Its public verification system uses report-number pages under verifiedbyvanguard.com, but publication is opt-in and older records may not have been backfilled. A missing search result therefore remains unresolved; it is not evidence that a certificate is false. The exact record page is preferable to a generic search destination when Vanguard has published one.
PeptideCritic's multi-lab work provides examples of same-lab agreement and cross-lab quantity variation. A July 2026 Reddit report describes a large HCG discrepancy that Vanguard reportedly attributed to a dilution error before retesting and reissuing the result. That is a material document-control and analytical-process incident, but it remains an attributed customer account rather than a regulator finding.
Public COA aggregators show broad use of Vanguard, but their certificate counts measure visibility rather than accuracy. An official Vanguard warning about a forged certificate also demonstrates why the issuer-controlled record matters: it supports impersonation risk in the market, not misconduct by the laboratory itself.
COA verification
Open the lab-issued dynamic QR link or search the official reporting hub, then compare the hosted report, report number, client, sample, lot, and panels.
Result handling
Use only when the official destination returns the same identifier and the material certificate fields agree.
Use only after a functioning official lookup explicitly returns no record for the submitted identifier.
Use when the official destination resolves the identifier but returns a different report, product, batch, or other material identity field.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Not applicable to the current Vanguard adapter; legacy contact-only reports remain unresolved until the issuer responds.
Use when the issuer identity, required identifier, or official workflow cannot be established from the available evidence.
Certificate structure
Retain and display every page in order. Vanguard reports in the corpus range from 1 to 5 pages.
Treat identity, purity, quantity, endotoxin, bioburden, sterility, heavy metals, residual solvents, and other panels separately; Vanguard's tier descriptions do not prove what an individual report contains.
Evidence boundaries
Review receipts
Public search record
Vanguard has substantial new 2026 coverage: official package and pricing pages, dedicated third-party lab reviews, and Reddit threads about report verification and conflicting analytical results. These sources support a useful process review but not a blanket accuracy verdict.
Sources
Reusable integration rule: For future vendors, retain the exact QR-issued UUID link, report number, complete PDF, and response fingerprint; treat legacy search/contact verification as a separate workflow.
Frequently asked questions
Yes — scope qualified. Vanguard is a legitimate operating laboratory with a current A2LA accreditation, named leadership, a Washington entity trail, and transparent peptide services. Its published accredited scope does not expressly cover the headline peptide assays it markets.
Vanguard publishes individual purity, quantity, identity, endotoxin, metals, microbiology, residual-solvent, and sterility offerings. Its order page lists standard turnaround of five to eight days and a 15-day sterility timeline that includes the 14-day incubation period.
ISO/IEC 17025 — limited published scope. A2LA certificate 6377.01 is valid through September 30, 2027. Its scope includes enumerated microbiology, trace elements, preservatives, and residual solvents; it does not expressly list peptide HPLC purity, LC-MS identity, quantity, endotoxin, or sterility.
Open the lab-issued dynamic QR link or search the official reporting hub, then compare the hosted report, report number, client, sample, lot, and panels.
The reviewed sources did not establish that vendors can purchase a passing result from Vanguard Laboratory. That is not an audited independence guarantee: sample selection, who pays, publication rights, blind-testing controls, and correction history still matter.
Physical-vial custody is unknown unless a documented chain connects the tested sample to the specific vial in hand.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Check the document
